Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1989-01-03
1990-01-30
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514178, 514182, 514879, A61K 3156
Patent
active
048973890
ABSTRACT:
A method of treating human suffering from central nervous system diseases, such as Alzheimer's disease, Parkinson's disease, senile dementia. The treatment consists of inducing into the patient's blood stream at least one from the group consisting of: sex hormones and anabolic hormones. Growth hormone is also being used in those patients in advanced stages of the disease, or in those patients where it has been determined that a low level of growth hormone is present. A method of diagnosing Alzheimer's disease, senile dementia, by the determination of the levels of the hormones somatotropin (human growth hormone) and somatomedin-C (IGF-I) after the administration of the Aroonsakul-Allen provocative test is also disclosed. Blood-sera samples are taken at certain time periods after the administration of L-Dopa, and the samples are tested for the levels of these hormones. These levels are then compared against the levels for normal subjects.
REFERENCES:
patent: 3274060 (1966-09-01), Bossinger
patent: 4746674 (1988-05-01), Pierpaoli et al.
Hagino, CA 95:3943, (1981).
Cotzias et al., CA 86:50823s, (1976).
Fillit et al., Biosis:58220, (1986).
LandOfFree
Treating central nervous system diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating central nervous system diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating central nervous system diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1923535